The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

被引：40

作者：

Lamarque, Mathilde ^{[1
]}

Raynaud, Sophie ^{[1
,2
]}

Itzykson, Raphael ^{[1
]}

Thepot, Sylvain ^{[1
,3
]}

Quesnel, Bruno ^{[1
,4
]}

Dreyfus, Francois ^{[1
,5
]}

Rauzy, Odile Beyne ^{[1
,6
]}

Turlure, Pascal ^{[1
,7
]}

Vey, Norbert ^{[1
,8
]}

Recher, Christian ^{[1
,6
]}

Dartigeas, Caroline ^{[1
,9
]}

Legros, Laurence ^{[1
,2
]}

Delaunay, Jacques ^{[1
,10
]}

Visanica, Sorin ^{[1
,11
]}

Stamatoullas, Aspasia ^{[1
,12
]}

Fenaux, Pierre ^{[1
,3
]}

Ades, Lionel ^{[1
,3
]}

机构：

[1] Grp Francophone Myelodysplasies, Bobigny, France

[2] Univ Nice Sophia Antipolis, Fac Med, Nice, France

[3] Univ Paris 13, Hop Avicenne, Paris, France

[4] CHU Lille, Serv Malad Sang, F-59037 Lille, France

[5] Univ Paris 05, Hop Cochin, Paris, France

[6] Ctr Hosp Univ, Hop Purpan, Toulouse, France

[7] Ctr Hosp Univ, Hop Dupuytren, Limoges, France

[8] Inst J Paoli I Calmettes, F-13009 Marseille, France

[9] CHU Tours, Tours, France

[10] CHU Nantes, F-44035 Nantes 01, France

[11] Ctr Hosp Metz, Metz, France

[12] Ctr Henri Becquerel, F-76038 Rouen, France

来源：

BLOOD | 2012年 / 120卷 / 25期

关键词：

PROGNOSTIC SCORING SYSTEM; MYELODYSPLASTIC SYNDROMES;

D O I：

10.1182/blood-2012-09-453555

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5084 / 5085

页数：2

共 4 条

[1] Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [J].

Cheson, Bruce D. ;

Greenberg, Peter L. ;

Bennett, John M. ;

Lowenberg, Bob ;

Wijermans, Pierre W. ;

Nimer, Stephen D. ;

Pinto, Antonio ;

Beran, Miloslav ;

de Witte, Theo M. ;

Stone, Richard M. ;

Mittelman, Moshe ;

Sanz, Guillermo F. ;

Gore, Steven D. ;

Schiffer, Charles A. ;

Kantarjian, Hagop .

BLOOD, 2006, 108 (02) :419-425

[2] Revised International Prognostic Scoring System for Myelodysplastic Syndromes [J].

Greenberg, Peter L. ;

Tuechler, Heinz ;

Schanz, Julie ;

Sanz, Guillermo ;

Garcia-Manero, Guillermo ;

Sole, Francesc ;

Bennett, John M. ;

Bowen, David ;

Fenaux, Pierre ;

Dreyfus, Francois ;

Kantarjian, Hagop ;

Kuendgen, Andrea ;

Levis, Alessandro ;

Malcovati, Luca ;

Cazzola, Mario ;

Cermak, Jaroslav ;

Fonatsch, Christa ;

Le Beau, Michelle M. ;

Slovak, Marilyn L. ;

Krieger, Otto ;

Luebbert, Michael ;

Maciejewski, Jaroslaw ;

Magalhaes, Silvia M. M. ;

Miyazaki, Yasushi ;

Pfeilstoecker, Michael ;

Sekeres, Mikkael ;

Sperr, Wolfgang R. ;

Stauder, Reinhard ;

Tauro, Sudhir ;

Valent, Peter ;

Vallespi, Teresa ;

van de Loosdrecht, Arjan A. ;

Germing, Ulrich ;

Haase, Detlef .

BLOOD, 2012, 120 (12) :2454-2465

[3] Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine [J].

Itzykson, Raphael ;

Thepot, Sylvain ;

Quesnel, Bruno ;

Dreyfus, Francois ;

Beyne-Rauzy, Odile ;

Turlure, Pascal ;

Vey, Norbert ;

Recher, Christian ;

Dartigeas, Caroline ;

Legros, Laurence ;

Delaunay, Jacques ;

Salanoubat, Celia ;

Visanica, Sorin ;

Stamatoullas, Aspasia ;

Isnard, Francoise ;

Marfaing-Koka, Anne ;

de Botton, Stephane ;

Chelghoum, Youcef ;

Taksin, Anne-Laure ;

Plantier, Isabelle ;

Ame, Shanti ;

Boehrer, Simone ;

Gardin, Claude ;

Beach, C. L. ;

Ades, Lionel ;

Fenaux, Pierre .

BLOOD, 2011, 117 (02) :403-411

[4] Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System [J].

Schanz, Julie ;

Steidl, Christian ;

Fonatsch, Christa ;

Pfeilstoecker, Michael ;

Noesslinger, Thomas ;

Tuechler, Heinz ;

Valent, Peter ;

Hildebrandt, Barbara ;

Giagounidis, Aristoteles ;

Aul, Carlo ;

Luebbert, Michael ;

Stauder, Reinhard ;

Krieger, Otto ;

Garcia-Manero, Guillermo ;

Kantarjian, Hagop ;

Germing, Ulrich ;

Haase, Detlef ;

Estey, Elihu .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :1963-1970

← 1 →